{"name":"Nxera Pharma UK Limited","slug":"nxera-pharma-uk-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"HTL0016878.HCl Solution 10 mg","genericName":"HTL0016878.HCl Solution 10 mg","slug":"htl0016878-hcl-solution-10-mg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"HTL0016878.HCl Solution 10 mg","genericName":"HTL0016878.HCl Solution 10 mg","slug":"htl0016878-hcl-solution-10-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNUDY4YUQ1N1JoZzV0X3BPS1R1VjJNd3ZyT1JRb2RDTjBKOGVzZm9teUM5ZFF3M00xb3BYcWJCLWdIX0FkVmpRU2RBZHB0THFxMG5PblFnUGVwdGswWTVXVFFEZUpDZU1JeXhPU1NENEg5MjJ5aVVCOUViVjA1MWRVdkZLb3NYMzluWC1qcDVud0FSTGNZX3FwQWo4R1NrS21QM296MFkteFRnY1NzVWJxMkhGSzN5TG96NVVVRzUtUEN2SF9xMzZsZzN6VGtfTGhoMkgtMFJIWVpOSHM?oc=5","date":"2026-03-31","type":"deal","source":"GlobeNewswire","summary":"Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly - GlobeNewswire","headline":"Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-04","type":"pipeline","source":"The Manila Times","summary":"Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea - The Manila Times","headline":"Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOeklLLUNFX1pQRVZfejc0dWFHVlZUZzlqNEc4T0E2LXBuNWFFMHpHVVpNWjdWbHphd0RkaWU4eEhxQ3RPMGJYNU1UTmdRbHNyVUlSZ2xEaGJmSF85aFZTZ01JUGpPN2FPZWV0dG1oOVFEa1hEODhMYXVGN0pxUzBrMkdNVHNTR0lUbmhSRVB3WXUwTkh2NkNDMjlaWW9fTGZMcFl2cGp6YktwMjlyQUVjY1Q1V1N2VnY5REI0NHdBWGFtbFRJQlE?oc=5","date":"2026-02-13","type":"pipeline","source":"GlobeNewswire","summary":"Nxera Pharma Proposes Changes to its Board of Directors - GlobeNewswire","headline":"Nxera Pharma Proposes Changes to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTFNGemt1cnhpUE1Ba0p6dUFxNmxLR1lveHFURFotOVRxaDl0VFVMcW8yb3FPQk92cEk1NElmcjUxZXRuM1dnVHNtREFsYjVCMjNsT1VBSUpiVWRXdE1DVVF1M3k4aGtQR3ZBX2Z3Q3JpN1RzVHZXZmp5OVQwYmJRTngydjdMUHM2?oc=5","date":"2026-02-12","type":"deal","source":"Yahoo Finance","summary":"Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company - Yahoo Finance","headline":"Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNelVfcDVOOC1qdnVIMnhPWGRlVW1KQTQ5U216cEthNDZmY1cxYXkzVGhUd0ZVZDUyZ0lTMlZLenQ1alYySXBDWjRNQlI4aFdXandUWVlpVTd0N0EwZlp5XzQ3VWNYUy1KNHlOR0xuNHJYTTV2a3Y3a2REY2lZaEcwZU9sWWtlNHpzcm10Mnh4N2tvcDN1NWFhTFZadnVDMno4dllVWEUzLWtTM3cyM1ZJLW9OLV9FZHEzVnoyWnRBX200UFhuMXNDeVFiOE9rTFg1RmJqNW1mQ2xtWVVhNWRHcFZKbVlXME94UC04?oc=5","date":"2026-02-12","type":"pipeline","source":"GlobeNewswire","summary":"Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewswire","headline":"Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPaXBwYTZNa2N1RzIyLVFnenY2aFBuNnQ4MERxWVR0V3NGQldvdnVfMHJqbnRmY3JhMkZTVmZSSWJRMWlYc0JySW94c2VyN0hpQXNzelZFT3I5S0VPUEdocTJDVmVvTGtEd3lvQU1NZWNjUG1GZ2dMUzJsQjZvQjdIMVZvNHk3bW9GLUFhU0NNbFVHVDNYUUV5cjh4TQ?oc=5","date":"2026-01-08","type":"patent","source":"BioWorld News","summary":"New 3CLpro inhibitors disclosed in Nxera Pharma patent - BioWorld News","headline":"New 3CLpro inhibitors disclosed in Nxera Pharma patent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxPcFdRc1BLWmtwWmtFS2t4UmZxakdBSGlRc21CRS1RSGYwRXAyLTdVQWppRTM4dzZxYVlRQzVxNVRIVGVTandqeEYwenVyTFFVenJOam1hODlqeF9VQ05sV3VublozMmktNHRPcVNwdm0talcwZEsxLTdtb2dVRFpDS3JkRWc5X0UtTjJjeGdBVVp6aE9EMjV0VFlDcFM1MDN0bTdsNEczSGxNQlI5d3BLMU9KRzR0OF9EWUxGOVY2YjgxTk4tZ1FMbkNKU1J6VC1jTnFUbGFRNDZQUmFaMUJpS3lKTHNNd292NVdLNVYzLWtZaU90OW9OVHpDSE0yTXo4MGJpNmtRRDl5ZnpBNE1kM1BUWmVDM3l2MTdid2JDQ3MzYWgzelZCQi1LOGgzYnE2eU80ZEp2NkFfZzBISVhFRnZWRkpaVl9QekEyZw?oc=5","date":"2026-01-08","type":"deal","source":"GlobeNewswire","summary":"Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties - GlobeNewswire","headline":"Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOTmpFdDRVUlNMNXhpS2hfMjcxRWg3WVdjOTRqYjlFbi0yWUF1TWFWanFTZlR4TmZoNXJkRGFtSHhRMzJ4eUMtdlp6WWhYaHRTU0VzeFVmOGlnMlpYX1RDd3MwMFZva2Y4Yl9rN0dMOGc2VzN4WVR1Qk1FR3RERnZYOXlRZE8yMVczNEpoR0RHQmNqVEdOTko0QWFPa3l2Q3lZQ0E?oc=5","date":"2025-11-16","type":"pipeline","source":"Business Weekly","summary":"Cambridge jobs to go in Nxera Pharma's restructuring blueprint - Business Weekly","headline":"Cambridge jobs to go in Nxera Pharma's restructuring blueprint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNdjhXVjVTMzE4b2gzazVheXY4ZkVhRi1Dcno5Tm5JRXBNbVRtM21ibnZYZGJySUtpY3B4bWdyMk0xMWoxX3BPZ2RuLW94d3hkcm9iV09tZi04YVd6ZExZOGliUFpZLTFscC1YbWZRaF92Vy1ud28ycG9KNTY1OFdIeDZkTnlMQk91VmFWclFR?oc=5","date":"2025-11-16","type":"pipeline","source":"Yahoo Finance UK","summary":"Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel - Yahoo Finance UK","headline":"Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQMGVYSk5EVUZHOGJBOU9nTjJyczNnOE9ad1VJYXNVS0hQR0h5VnRYRlVlWDJJMU1OX0N1MGRKb05Uc2p4VVpEb09iWEdOd1loNUJaQ21Ed2haY00wMFZxRnhCY1NfbWhWWjM2QXRxU2dfNlJ6cHR6NDhhZ2w0dlR0aG52YVIyN1lVRkdELVJRSi01RkZCVU96R205d1VmaHdzMi1uS1Q3SlJiaXRvcFlQM1QxQ1pXZV9GMzlTWmR6U2JhQW9sYnFaSmNfdUZpTXlqNlI3eWpLTF9UajRzTXdESW9WUXFxanBpYjNib3RZN29YMW1fVDZzMDR4Wi1PU2xZSVZac3RObjZsNHVWNUh1Vl9tcFFPRUZTTTlFWHY0bVBIRXFKRGZiVkJybVJPdw?oc=5","date":"2025-09-16","type":"pipeline","source":"GlobeNewswire","summary":"Nxera Pharma and Cancer Research UK Announce First Patient - GlobeNewswire","headline":"Nxera Pharma and Cancer Research UK Announce First Patient","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQR2QxRWJsY2lWUUNZd2JqTGNnYmN0MGQwQTFwakFGV0NjblN0YjRBREZBcWw3WUZ6bllyYXp3Vi1pWlFzSXhiUEN6SEo1ZzZ1Y1hHRUtsaG56azU2QlRaTEJfZm9URGxCNVVtWVJoNzBYRnllS1A5bTJMbEM4WldIYWM3NHdkZ29WaUhGUnlWb0pYRms1TDZLWjJ1WHEtUVU?oc=5","date":"2025-02-27","type":"deal","source":"Business Weekly","summary":"Nxera Pharma clinches millions from autoimmune disease deal - Business Weekly","headline":"Nxera Pharma clinches millions from autoimmune disease deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOdEZxMUppeHI4cTNPX2xuODRpdGVXdWhScHdlSTdBN3pjbzFkQVdSckRsRVNYYUx4UThzc2ZjeEk4OWFtU3I1ZGxxdlNZY2xYejdqODZFZmVpZEtGWGFtdk5qTS1nMTdKSkFjV1BPRHBNbk1fSFd0TUxCeThwcEFueXQ0YXZEV0FUcWt0YjQwRFR5V290a09vSmRNZjZvMjRlSTU0RW1QZUZ4MERzczlNWGtnZnNtcTQ?oc=5","date":"2024-09-25","type":"regulatory","source":"cambridgenetwork.co.uk","summary":"Nxera Pharma receives approval of QUVIVIQ (daridorexant) in Japan for the treatment of insomnia - cambridgenetwork.co.uk","headline":"Nxera Pharma receives approval of QUVIVIQ (daridorexant) in Japan for the treatment of insomnia","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}